Patricia Ried, PhD
Women's Health · Chester, PANPI 1942578828
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $590, 2.3 times the $255 reported in 2021.
Across 46 payments — averaging $23.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aspira Women's Health Inc$255
- Astellas Pharma US Inc$152
- Sage Therapeutics, LLC$118
- Exeltis, USA Inc.$98
- Coopersurgical, Inc.$89
- Mayne Pharma Commercial LLC$85
- plus $291 from 9 others
What the payments were for
- Food & beverage$1,088100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aspira Women's Health Inc | 3 | $255 |
| Astellas Pharma US Inc | 8 | $152 |
| Sage Therapeutics, LLC | 5 | $118 |
| Exeltis, USA Inc. | 6 | $98 |
| Coopersurgical, Inc. | 4 | $89 |
| Mayne Pharma Commercial LLC | 6 | $85 |
| AbbVie | 3 | $68 |
| Shield Therapeutics Inc | 3 | $48 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Organon | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Exact Sciences | 1 | $20 |
| Bayer | 1 | $19 |
How this compares
$1,088 in reported general payments places this provider in the 80th percentile of 250 women's health providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $2,975 |
| Clobetasol Propionate | 31 | $1,791 |
| YuvafemEstradiol | 11 | $1,642 |
| Fluconazole | 38 | $364 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 26 | $249 |
| Norethindrone | 11 | $248 |
| ProgesteroneProgesterone, Micronized | 11 | $215 |
| Metronidazole | 11 | $108 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Other women's health in Chester
- Katie BardChester$805
- Shawana MoorePhiladelphia$72K
- Anita BoothFarrell$12K
- Kassandra PetitPhiladelphia$10K
- Mary WangPhiladelphia$8K
- Megan LaniganMechanicsburg$6K
- Lauren OppenheimBryn Mawr$5K
- Caroline GarrisonAllentown$4K
- Prisca SchneiderBryn Mawr$4K
- Karin YoungPittsburgh$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.